CJMB vs TECH · rev $6.6M vs P/E 65, rev $1.22B
Callan JMB Inc. Common Stock (CJMB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Callan JMB Inc. Common Stock (CJMB) is a integrated freight & logistics company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CJMB revenue for 2024-12-31 was $6.6M. Net income was -$2.3M. Revenue was down 50.3% from 2023-12-31 to 2024-12-31. CJMB currently screens at market cap $4.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CJMB currently screens at market cap $4.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CJMB and TECH stock pages for the full models.
Not investment advice.